Managing Anaemia in Chronic Kidney Disease: Why You Feel Tired and How to Treat It

Introduction

Anaemia in chronic kidney disease is considered to be one of the most frequent and debilitating complications in patients at all stages of kidney disease. If you always feel tired, short of breath, or mentally cloudy despite getting plenty of rest, anaemia could be the underlying cause. It is important to understand why kidney disease leads to anaemia and how current treatments can manage it.

Why Kidney Disease Causes Anaemia

The hormone produced by healthy kidneys is erythropoietin (EPO), which stimulates the bone marrow to produce red blood cells. In Chronic Kidney Disease (CKD), the kidneys are damaged and do not produce enough EPO. Consequently, the production of red blood cells in the body also drops. This reduces haemoglobin levels, further worsening anaemia.

Low haemoglobin levels mean less oxygen is carried to the body tissues. The lack of oxygen is why patients with CKD experience some symptoms, such as:

• Fatigue

• Shortness of breath

• Reduced exercise tolerance

• Dizziness

• Palpitations

Furthermore, patients with CKD may develop iron deficiency due to reduced absorption, chronic inflammation (functional iron deficiency), and blood loss during dialysis. 

Therefore, the pathophysiology of anaemia in CKD is complex, and low EPO levels, iron deficiency, inflammation, and shortened red cell survival are all involved.

Symptoms of Anaemia in Kidney Failure

The symptoms of anaemia in kidney failure can get worse as the CKD advances and the condition of the patient deteriorates. Some of the common symptoms of anaemia in kidney failure include:

• Pale skin

• Cold hands and feet

• Severe fatigue

• Difficulty focusing

• Increased strain on the heart

• Headaches

• Reduced concentration

Anaemia should be treated promptly. In the advanced stages, if the anaemia is left untreated, the heart has to work harder to pump the blood. This increases the risk of left ventricular hypertrophy and even heart failure in some severe cases. Thus, anaemia is not only a condition of fatigue but also has severe implications for the individual's heart health.

Haemoglobin Targets in CKD

Maintaining safe haemoglobin levels is crucial for the proper functioning of the body's functions. The expected haemoglobin targets should be maintained to ensure the patient's safety with Chronic Kidney Disease. Let’s understand the target haemoglobin levels for different sections of society using a table.

Overcorrection beyond recommended levels may increase clotting and also raise the risks of blood pressure-related health concerns. Hence, precision monitoring is essential to maintain the haemoglobin levels within the expected range.

CKD Anaemia Treatment Options

Contemporary management of CKD anaemia involves iron therapy, erythropoiesis-stimulating agents (ESAs), and newer oral agents to eliminate anaemia from the patient’s body. Let’s understand each one of them in more detail.

1. Iron Therapy

Iron is the key component of haemoglobin. Iron therapy is thus extremely beneficial for maintaining the haemoglobin and alleviating anaemia. Oral iron is used in the early stages of CKD, but its absorption is generally poor. Intravenous (IV) iron is generally prescribed in advanced CKD and dialysis patients because of its improved absorption.

2. Erythropoietin Injections (ESA Therapy)

EPO injections are synthetic and act by stimulating the bone marrow to produce more red blood cells (RBCs). These are given subcutaneously or intravenously to improve the patient's haemoglobin and iron levels.

3. HIF-PHD Inhibitors

Newer oral agents called HIF-PHD inhibitors are used, which act by stimulating endogenous EPO secretion and enhancing iron metabolism. Thereby helping in reducing anaemia or iron deficiency.

Treatment Comparison

Using a table, let’s compare the different treatment options to get a more comprehensive view and make the best choice.

 

 

Can Renal Anaemia Be Treated with Diet Alone?

Diet is one of the causes, but it cannot be the sole treatment for CKD anaemia. Diet is definitely a major part of staying healthy, but CKD anaemia cannot be managed solely with diet. Other factors are also significant. Iron-rich diets like spinach and beans are very useful, but due to inflammation and low absorption, their use is limited.

NU Hospitals Anaemia Management Protocol (EEAT Focus)

At NU Hospitals, anaemia management is customised and evidence-driven. This includes the following:

• Iron profiling (Ferritin and TSAT evaluation)

• Customised EPO therapy

• Optimisation of Haemoglobin levels

• Evaluation of Blood Pressure and Thrombosis Risk

• Combination of IV iron therapy, if needed

The aim is to deliver the best anaemia management without exacerbating cardiovascular risk. With the introduction of personalised diagnostics and the latest treatment modalities, such as ESAs and HIF-PH inhibitors, NU Hospitals provides the best possible energy replacement and management for patients with Chronic Kidney Disease and anaemia.

Conclusion

Anaemia in chronic kidney disease is caused by decreased erythropoietin secretion and disturbances in iron metabolism. The clinical problems are fatigue, shortness of breath, and heart failure. The management involves iron supplements, erythropoietin injections, and HIF-PH inhibitors. The haemoglobin concentration needs to be closely monitored for optimal patient well-being. At NU Hospitals, personalised management of anaemia helps in the safe correction and improved quality of life. For patients seeking a leading healthcare facility for treatment with the most advanced technology and equipment, NU Hospitals is a reliable option and has been one of the most trusted healthcare institutions over the past years.